125 related articles for article (PubMed ID: 30959058)
21. Formulation and processability screening for the rational design of ethylene-vinyl acetate based intra-vaginal rings.
Koutsamanis I; Eder S; Beretta M; Witschnigg A; Paudel A; Nickisch K; Friedrich M; Eggenreich K; Roblegg E
Int J Pharm; 2019 Jun; 564():90-97. PubMed ID: 30999046
[TBL] [Abstract][Full Text] [Related]
22. A prospective randomized comparative study of the effects of intranasal and transdermal 17 beta-estradiol on postmenopausal symptoms and vaginal cytology.
Odabaşi AR; Yüksel H; Demircan SS; Kaçar DF; Culhaci N; Ozkara EE
J Postgrad Med; 2007; 53(4):221-7. PubMed ID: 18097108
[TBL] [Abstract][Full Text] [Related]
23. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
Stanczyk FZ; Archer DF; Bhavnani BR
Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
[TBL] [Abstract][Full Text] [Related]
24. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
Cicinelli E
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
[TBL] [Abstract][Full Text] [Related]
25. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
Landgren BM; Hall PE; Cekan SZ
Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
Speroff L
Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
[TBL] [Abstract][Full Text] [Related]
27. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Duijkers I; Klipping C; Heger-Mahn D; Fayad GN; Frenkl TL; Cruz SM; Korver T
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):245-254. PubMed ID: 30203681
[TBL] [Abstract][Full Text] [Related]
28. Effect of indomethacin on estrogen-induced luteolysis in the ewe.
Lewis PE; Warren JE
Prostaglandins; 1977 May; 13(5):957-63. PubMed ID: 866703
[TBL] [Abstract][Full Text] [Related]
29. Development of an injection molded ethylene-vinyl acetate copolymer (EVA) intravaginal insert for the delivery of progesterone to cattle.
Cappadoro AJ; Luna JA
Anim Reprod Sci; 2015 Jul; 158():104-8. PubMed ID: 26022232
[TBL] [Abstract][Full Text] [Related]
30. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study.
Lewin A; Pisov G; Turgeman R; Fatum M; Shufaro Y; Simon A; Laufer N; Revel A; Reubinoff B; Safran A
Gynecol Endocrinol; 2002 Apr; 16(2):131-6. PubMed ID: 12012623
[TBL] [Abstract][Full Text] [Related]
31. Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy.
Young IC; Srinivasan P; Shrivastava R; Janusziewicz R; Thorson A; Cottrell ML; Sellers RS; Sykes C; Schauer A; Little D; Kelley K; Kashuba ADM; Katz D; Pyles RB; García-Lerma JG; Vincent KL; Smith J; Benhabbour SR
Biomaterials; 2023 Oct; 301():122260. PubMed ID: 37549505
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.
Moss JA; Malone AM; Smith TJ; Kennedy S; Nguyen C; Vincent KL; Motamedi M; Baum MM
Antimicrob Agents Chemother; 2013 Aug; 57(8):3994-7. PubMed ID: 23752507
[TBL] [Abstract][Full Text] [Related]
33. A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review.
Simon JA; Archer DF; Constantine GD; Pickar JH; Amadio JM; Bernick B; Graham S; Mirkin S
Maturitas; 2017 May; 99():51-58. PubMed ID: 28364869
[TBL] [Abstract][Full Text] [Related]
34. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats.
Mannino CA; South SM; Inturrisi CE; Quinones-Jenab V
J Pain; 2005 Dec; 6(12):809-16. PubMed ID: 16326369
[TBL] [Abstract][Full Text] [Related]
36. Induced and synchronized estrus in cattle: dose titration of estradiol benzoate in peripubertal heifers and postpartum cows after treatment with an intravaginal progesterone-releasing insert and prostaglandin F2alpha.
Lammoglia MA; Short RE; Bellows SE; Bellows RA; MacNeil MD; Hafs HD
J Anim Sci; 1998 Jun; 76(6):1662-70. PubMed ID: 9655587
[TBL] [Abstract][Full Text] [Related]
37. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
[TBL] [Abstract][Full Text] [Related]
38. What regulates placental steroidogenesis in 90-day pregnant ewes?
Weems YS; Kim L; Tsuda V; Yin C; Weems CW
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
[TBL] [Abstract][Full Text] [Related]
39. Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules).
Lobo RA; Liu J; Stanczyk FZ; Constantine GD; Pickar JH; Shadiack AM; Bernick B; Mirkin S
Menopause; 2019 Jul; 26(7):720-727. PubMed ID: 30694918
[TBL] [Abstract][Full Text] [Related]
40. 17β-estradiol and progesterone independently augment cutaneous thermal hyperemia but not reactive hyperemia.
Brunt VE; Miner JA; Meendering JR; Kaplan PF; Minson CT
Microcirculation; 2011 Jul; 18(5):347-55. PubMed ID: 21426437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
